DNA Methylation Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32

1
Global DNA Methylation Market Research and
Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "DNA Methylation Market Global Industry
  Trends, Share, Size, Growth, Opportunity and
  Forecast 2024-2032," the global DNA methylation
  market size reached US 1.4 Billion in 2023.
• Deoxyribonucleic acid (DNA) methylation refers to
  a biological process in which a methyl group is
  added to the cytosine base of a DNA molecule. It
  is an epigenetic modification process that alters
  gene expression patterns without changing the
  underlying DNA sequence. It is analyzed through
  various technologies, such as polymerase chain
  reaction (PCR), microarray, bisulfite sequencing,
  immunoprecipitation (IP), and nanopore
  sequencing.
• DNA methylation is widely used for disease
  diagnosis and prognosis, prenatal screening, drug
  development, epigenetic research, and forensic
  analysis. It provides a deeper understanding of
  disease mechanisms and progression, which aids in
  early disease detection, improving clinical
  outcomes, minimizing complications, and enhancing
  patient satisfaction.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/dna-methylation-market/
  requestsample

4
Report Description

• Global DNA Methylation Market Trends
• The escalating prevalence of chronic diseases,
  such as cancer, diabetes, hypertension,
  arthritis, Alzheimers disease, and
  cardiovascular diseases (CVDs), is one of the key
  factors driving the market growth. DNA
  methylation is widely used as a biomarker to
  identify epigenetic changes associated with
  certain conditions, thus allowing early disease
  detection, improving patient outcomes, and
  reducing healthcare costs. In addition to this,
  the rising geriatric population with high
  susceptibility to developing chronic conditions
  is acting as another growth-inducing factor.
  Furthermore, the increasing adoption of DNA
  methylation as a non-invasive diagnostic tool for
  monitoring diseases, which enhances patient
  comfort and reduces the risk of complications, is
  providing an impetus to the market growth.
  Additionally, the recent development of
  single-cell sequencing technology that allows
  fast, more accurate, and in-depth analysis of DNA
  methylation patterns is positively influencing
  the market growth. Moreover, the increasing
  applications of DNA methylation in prenatal
  screening to detect chromosomal abnormalities and
  identify various genetic disorders, such as down
  syndrome, muscular dystrophy, and cystic
  fibrosis, is facilitating the market growth.
  Other factors, including rising healthcare
  expenditure, the increasing utilization of DNA
  methylation to develop new plant varieties,
  extensive research and development (RD)
  activities, and growing demand for precision
  medicine, are anticipated to drive the market
  growth.
• Looking forward, the market value is expected to
  reach US 4.5 Billion by 2032, exhibiting a CAGR
  of 13.5 during 2024-2032.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/dna-methylation-market

5
Report Segmentation

• Breakup by Product
• Consumables
• Kits and Reagents
• Enzymes
• Instrument and Software
• Breakup by Technology
• Polymerase Chain Reaction (PCR)
• Microarray
• Sequencing
• Others
• Breakup by Application
• Gene Therapy

6
Report Segmentation

• Clinical Research
• Diagnostics
• Others
• Breakup by End User
• Hospital and Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies
• Research and Academia
• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• Abcam plc.
• Active Motif Inc.
• Diagenode S.A. (Hologic Inc.)
• EpiGentek Group Inc.
• Illumina Inc.
• Merck KGaA
• New England Biolabs Inc.
• PerkinElmer Inc.
• Qiagen N.V.
• Thermo-Fisher Scientific Inc.
• Zymo Research Corporation

8
Key Questions Answered in the Report
9
Key Questions Answered in the Report
10
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global DNA Methylation
  Market    5.1    Market Overview    5.2  
   Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Product    6.1  
   Consumables        6.1.1 Market Trends       
  6.1.2 Market Forecast    6.2    Kits and
  Reagents        6.2.1 Market Trends       
  6.2.2 Market Forecast    6.3    Enzymes       
  6.3.1 Market Trends        6.3.2 Market
  Forecast       

11
Table of Contents

•     6.4    Instrument and Software        6.4.1
  Market Trends        6.4.2 Market Forecast7  
   Market Breakup by Technology    7.1  
   Polymerase Chain Reaction (PCR)        7.1.1
  Market Trends        7.1.2 Market Forecast   
  7.2    Microarray        7.2.1 Market Trends   
      7.2.2 Market Forecast    7.3    Sequencing 
        7.3.1 Market Trends        7.3.2 Market
  Forecast    7.4    Others        7.4.1 Market
  Trends        7.4.2 Market Forecast8    Market
  Breakup by Application    8.1    Gene Therapy 
        8.1.1 Market Trends        8.1.2 Market
  Forecast    8.2    Clinical Research       
  8.2.1 Market Trends        8.2.2 Market
  Forecast    8.3    Diagnostics        8.3.1
  Market Trends        8.3.2 Market Forecast   
  8.4    Others        8.4.1 Market Trends       
  8.4.2 Market Forecast
• For more information, visit https//www.imarcgrou
  p.com/dna-methylation-market/toc

12
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

13
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com